Micropathology Ltd

Micropathology Ltd is an independent United Kingdom pathology laboratory specialising in the rapid diagnosis and management of infectious and genetic disease. It was established in 1995 by Dr David Burnett and Professor Colin Fink as a company focused on rapid diagnosis and research relating to infectious disease and host immune responses. The company was initially based within the University of Birmingham's Institute of Research and Development, and in 1999 it relocated to its current facilities at the University of Warwick Science Park, where it has continued to expand its diagnostic and research capabilities. The laboratory offers a clinically supported diagnostic service built around molecular and immunological methods. Its service lines include sequencing (both Sanger and next-generation sequencing), pathogen detection with rapid identification of pathogens and host responses, antibody and antigen detection in human and veterinary samples, and genetics services such as genetic profiling for human identification and testing for haemochromatosis, prothrombin and Factor V mutations. Alongside routine diagnostics, Micropathology undertakes grant-aided biomedical research with university and industry collaborators, including contract research and clinical trials for external organisations and continuing in-house assay development. Micropathology plays a significant role in infection surveillance for the UK transplant population, delivering molecular monitoring and diagnostic services to tertiary and specialist referral centres across the NHS. It also provides acute infectious disease testing and specialist molecular investigations for NHS hospitals throughout the United Kingdom. The company maintains close working relationships with academic collaborators and university departments, keeping applied research and clinical practice tightly integrated and supporting ongoing innovation in molecular diagnostic assay development, validation and translation into routine diagnostic use. In 2003 Micropathology received the Queen's Award for Enterprise: Innovation in recognition of its pioneering work in rapid molecular diagnostics and its contribution to improving clinical response times for infectious disease management. The laboratory was first awarded UKAS accreditation to ISO 15189:2012 in November 2017. The company states that it works to the highest possible standards, subscribing to UK and international standards of accreditation, quality assurance and best practice, and it welcomes ongoing contact with clients to help address the problems of infectious disease.

Micropathology Ltd was established in 1995 by Dr David Burnett and Professor Colin Fink as an independent company specialising in rapid diagnosis and research relating to infectious disease and host immune responses. The company was initially based within the University of Birmingham, Institute of Research and Development. In 1999 it relocated to its current facilities at the University of Warwick Science Park, where it has continued to expand its diagnostic and research capabilities. In 2003 Micropathology was honoured with the Queen's Award for Enterprise: Innovation in recognition of its pioneering work in rapid molecular diagnostics and its contribution to improving clinical response times for infectious disease management. The laboratory was first awarded UKAS accreditation to ISO 15189:2012 in November 2017. Over time the company has grown into a provider of molecular monitoring and diagnostic services for the UK transplant population, delivering services to tertiary and specialist referral centres across the NHS, as well as acute infectious disease testing and specialist molecular investigations for NHS hospitals throughout the United Kingdom. It maintains close working relationships with academic collaborators and university departments, supporting applied research and the translation of molecular diagnostic assays into routine diagnostic use. The company also undertakes grant-aided biomedical research, contract research and clinical trials for external organisations, alongside continuing in-house assay development.

• 2017

  First awarded UKAS accreditation to ISO 15189:2012 in November 2017.

• 2003

  Honoured with the Queen's Award for Enterprise: Innovation for pioneering work in rapid molecular diagnostics.

• 1999

  Relocated to current facilities at the University of Warwick Science Park.

• 1995

  Micropathology Ltd established by Dr David Burnett and Professor Colin Fink as an independent company specialising in rapid diagnosis and research relating to infectious disease and host immune responses.

Independent UK pathology laboratory offering clinically supported rapid molecular diagnostics for infectious and genetic disease, with strong academic links and NHS-facing specialist services.

• Sequencing

  Sanger and Next-Generation sequencing services.

• Pathogen Detection

  Rapid detection of pathogens and host responses.

• Antibody / Antigen Detection

  Rapid detection of specific antibodies in human and veterinary samples.

• Genetics

  Genetic profiling for human identification; haemochromatosis, prothrombin and Factor V mutation testing.

• Biomedical Research

  Grant-aided research with universities and other research companies; contract research and clinical trials.

1. 1Micropathology Ltd | Rapid Diagnosis Pathology Laboratory UKmicropathology.com
2. 2About Micropathology Ltd | UK Pathology Laboratorymicropathology.com
3. 3About Micropathology Ltd | UK Pathology Laboratorymicropathology.com
4. 4Pathology Testing Services | Micropathology Ltdmicropathology.com
5. 5Micropathology Ltd (United Kingdom)wikidata.org